Nicole W.: Deeply Moved to Receive the 2026 Office of Patient Experience Interpreter Services Partner in Excellence Award
Nicole W., Assistant Nurse Manager of the Stroke Program at Cedars-Sinai, shared on LinkedIn:
”A patient is having a stroke. Every second costs precious brain cells. And they don’t speak English.
The monitor is alarming. The team is moving fast.
And somewhere in that room, a terrified person cannot answer our questions, and cannot understand what’s happening to their own body.
This is not a communication inconvenience.
This is a life-or-death moment – and language is the difference between the right treatment and the wrong one.
That’s why I’m so deeply moved to receive the 2026 Office of Patient Experience Interpreter Services Partner in Excellence Award from Cedars-Sinai – and why being nominated by the
Interpreter Services team themselves means everything to me.
Our highly trained Cedars Sinai interpreters respond swiftly to show up in the hardest moments of people’s lives.
Not as a courtesy. As a clinical necessity, that protects lives, preserves dignity, and ensures a frightened patient and family is actually seen.
I’ve watched this team work. I’ve watched them translate chaotic scenes, and a cacophony of voices and commands, simultaneously to patients, family’s and care team members.
I’ve seen them bridge the gap between a family’s panic and a physician’s explanation. Between a patient’s symptoms and a care team’s understanding.
Between a person and their own medical care.
To the entire Interpreter Services team: this recognition belongs to YOU.
You nominated me, but you’re the reason I show up differently.
Thank you for the profound work you do every single day – for every patient, in every language.
Language access is not a luxury. It is patient safety.
Big thank you to the entire Patient Experience team for the beautiful celebration today.
So grateful to be a Cedars Sinai Nurse.”

Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering